Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

How far will medtech go to avoid mandatory standards?

This article was originally published in Clinica

Executive Summary

Should some European medical device standards be made mandatory? I can see many readers reel in horror. Yet, this is one of the possible answers to the question: What is the EU medical devices industry willing to accept in terms of tougher requirements to avoid the system of IVD-type Common Technical Specifications, or the involvement of European Medicines Agency (EMEA) for some medical devices? These options are now under consideration at the European Commission.

You may also be interested in...



EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency

Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.

First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve

Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.

First Danish Notified Body Named Under EU's Medical Device Regulation

The EU now has a total of 45 notified bodies under the MDR.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT041803

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel